Cargando…

Upper respiratory tract infections

Acute respiratory infections accounts for 20–40% of outpatient and 12–35% of inpatient attendance in a general hospital. Upper respiratory tract infections including nasopharyngitis, pharyngitis, tonsillitis and otitis media constitute 87.5% of the total episodes of respiratory infections. The vast...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Neemisha, Lodha, R., Kabra, S. K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 2001
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091368/
https://www.ncbi.nlm.nih.gov/pubmed/11838568
http://dx.doi.org/10.1007/BF02722930
_version_ 1783510009243500544
author Jain, Neemisha
Lodha, R.
Kabra, S. K.
author_facet Jain, Neemisha
Lodha, R.
Kabra, S. K.
author_sort Jain, Neemisha
collection PubMed
description Acute respiratory infections accounts for 20–40% of outpatient and 12–35% of inpatient attendance in a general hospital. Upper respiratory tract infections including nasopharyngitis, pharyngitis, tonsillitis and otitis media constitute 87.5% of the total episodes of respiratory infections. The vast majority of acute upper respiratory tract infections are caused by viruses. Common cold is caused by viruses in most circumstances and does not require antimicrobial agent unless it is complicated by acute otitis media with effusion, tonsillitis, sinusitis, and lower respiratory tract infection. Sinusitis is commonly associated with common cold. Most instances of rhinosinusitis are viral and therefore, resolve spontaneously without antimicrobial therapy. The most common bacterial agents causing sinusitis areS. pneumoniae, H. influenzae, M. catarrhalis,S. aureus andS. pyogenes. Amoxycillin is antibacterial of choice. The alternative drugs are cefaclor or cephalexin. The latter becomes first line if sinusitis is recurrent or chronic. Acute pharyngitis is commonly caused by viruses and does not need antibiotics. About 15% of the episodes may be due to Group A beta hemolytic streptococcus (GABS). Early initiation of antibiotics in pharyngitis due to GABS can prevent complications such as acute rheumatic fever. The drug of choice is penicillin for 10–14 days. The alternative medications include oral cephalosporins (cefaclor, cephalexin), amoxicillin or macrolides.
format Online
Article
Text
id pubmed-7091368
institution National Center for Biotechnology Information
language English
publishDate 2001
publisher Springer India
record_format MEDLINE/PubMed
spelling pubmed-70913682020-03-24 Upper respiratory tract infections Jain, Neemisha Lodha, R. Kabra, S. K. Indian J Pediatr Special Article Acute respiratory infections accounts for 20–40% of outpatient and 12–35% of inpatient attendance in a general hospital. Upper respiratory tract infections including nasopharyngitis, pharyngitis, tonsillitis and otitis media constitute 87.5% of the total episodes of respiratory infections. The vast majority of acute upper respiratory tract infections are caused by viruses. Common cold is caused by viruses in most circumstances and does not require antimicrobial agent unless it is complicated by acute otitis media with effusion, tonsillitis, sinusitis, and lower respiratory tract infection. Sinusitis is commonly associated with common cold. Most instances of rhinosinusitis are viral and therefore, resolve spontaneously without antimicrobial therapy. The most common bacterial agents causing sinusitis areS. pneumoniae, H. influenzae, M. catarrhalis,S. aureus andS. pyogenes. Amoxycillin is antibacterial of choice. The alternative drugs are cefaclor or cephalexin. The latter becomes first line if sinusitis is recurrent or chronic. Acute pharyngitis is commonly caused by viruses and does not need antibiotics. About 15% of the episodes may be due to Group A beta hemolytic streptococcus (GABS). Early initiation of antibiotics in pharyngitis due to GABS can prevent complications such as acute rheumatic fever. The drug of choice is penicillin for 10–14 days. The alternative medications include oral cephalosporins (cefaclor, cephalexin), amoxicillin or macrolides. Springer India 2001 /pmc/articles/PMC7091368/ /pubmed/11838568 http://dx.doi.org/10.1007/BF02722930 Text en © Dr. K C Chaudhuri Foundation 2001 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Special Article
Jain, Neemisha
Lodha, R.
Kabra, S. K.
Upper respiratory tract infections
title Upper respiratory tract infections
title_full Upper respiratory tract infections
title_fullStr Upper respiratory tract infections
title_full_unstemmed Upper respiratory tract infections
title_short Upper respiratory tract infections
title_sort upper respiratory tract infections
topic Special Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091368/
https://www.ncbi.nlm.nih.gov/pubmed/11838568
http://dx.doi.org/10.1007/BF02722930
work_keys_str_mv AT jainneemisha upperrespiratorytractinfections
AT lodhar upperrespiratorytractinfections
AT kabrask upperrespiratorytractinfections